ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Japanese Encephalitis: Clinical Presentations, Prognosis, Diagnosis And Treatment

Updated on March 27, 2014

Symptoms Of Japanese Encephalitis

Source

Clinical Features Of Japanese Encephalitis

The incubation period ranges from 5 to 15 days. Three stages are recognizable- prodrome, acute encephalitis and convalescence.

Prodromal stage: The onset may be gradual (4 to 5 days) or acute (12 to 24 hours) or abrupt (1 to 6 hours). The disease starts as a fever with chills, headache, meningism, convulsions, psychotic behaviour and coma. Majority of cases recover in 4 to 5 days and clinical diagnosis can be made only during epidemics.

Acute encephalitis stage: The fever persists at 400 to 410C, the pulse is rapid and neurological manifestations predominate. Symptoms such as convulsions (70%), altered sensorium (90%), focal neurological deficits, signs of meningeal irritation (30%) and coma supervene. Supra-nuclear ocular palsies are common. Cranial nerve palsies and papilledema are uncommon. These features help to identify JE from tiberculous meningitis. Rapid onset of paralysis such as hemiplegia or monoplegia is characteristic. Plantar responses are bilaterially extensor. Other manifestations of brain involvement include cerebella signs, extrapyramidal signs and dystonic postures.

Convalescence: Days to weeks after the encephalitic phase, the neurological manifestations subside to recover completely with time.

Prognosis: Complete recovery occurs in one-third of the cases, neurological sequelase in another one-third and mortality in the rest. In India, mortality rate is 25 to 45%, death being due to neuronal damage, cerebral edema, pulmonary edema or intercurrent complications. Prognosis has to be guarded since it is not always possible to predict the outcome from the clinical features. Neurological sequelae such as intellectual impairment, motor deficits, extra-pyramidal features and cerebella disturbances are common. Parkinsonism is uncommon and this stands in contrast to encephalitis lethargic. The first attack of JE produces immunity, but second attacks do occur since the immunity is not lifelong.

The Prophylaxis Against Japanese Encephalitis With Vaccine

Source

Diagnosis, Treatment And Prevention Of Japanese Encephalitis

Diagnosis

The clinical diagnosis is easy during epidemics, since disease often occurs sporadically, JE should always be considered in cases of encephalitis. Blood shows neutrophil leukocytosis. CSF shows lymphocytic pleocytosis. The cell count varies from 10 to 1000 cells/cmm, with an average of 100 to 200 cells. The CSF abnormalities may not be evident at the onset and repeat examination within 3 to 4 days may be necessary to demonstrate them. The CSF proteins may be raised to 50 to 150 mg/dl, sugar is usually normal.

Electroencephalographic abnormalities are present in the acute phase. The EEG findings are not helpful in predicting the outcome. The ECG may show nonspecific ST-T wave changes indicating myocarditis.

The final diagnosis is established by demonstrating the virus in autopsy or biopsy speciments of brain by fluorescence antibody techniques, or isolating the virus from CSF, or rarely from blood collected early in the disease.

Hemagglutination inhibition (HI) or complement fixing antibodies can be demonstrated in paired sera and these gives evidence of infection in retrospect.

Differential Diagnosis: Features of JE have to be distinguished from various types of meningitis and encephalitis, cerebral malaria, toxic encephalopatheis, cerebral tumours and Reye’s syndrome.

Treatment And Prevention

Treatment: There is no specific treatment. Supportive measures include the correction of fluid and electrolyte abnormalities, measures to control cerebral edema, anticonvulsants and maintenance of nutrition. Use of human immunoglobulin in a dose of 150 to 200 mg/Kg body weight early in the disease has been claimed to reduce the severity and mortality of the disease.

Prevention: Killed vaccines using Nakayama JE stain of the virus are available for prophylaxis. The frozen dried vaccine can be stored at 200C without losing potency for 3 to 4 years. The course of vaccination consists of two injections of 1 ml for adults and 0.5 ml for children given at an interval of 2 weeks.

Protection starts one month after the second dose. Booster doses are given at one year and subsequently at 3 to 4 year intervals. Vaccines using India strains of the virus are being tried experimentally. Vaccination should be performed during inter-epidemic periods in endemic areas. Anti mosquito measures help in avoiding outbreaks.

© 2014 Funom Theophilus Makama

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://hubpages.com/privacy-policy#gdpr

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)